Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens
Adrien Bosseboeuf, Delphine Feron, Anne Tallet, Cédric Rossi, Cathy Charlier, Laurent Garderet, Denis Caillot, Philippe Moreau, Marina Cardó-Vila, Renata Pasqualini, Wadih Arap, Alfreda Destea Nelson, Bridget S. Wilson, Hélène Perreault, Eric Piver, Pierre Weigel, François Girodon, Jean Harb, Edith Bigot-Corbel, Sylvie Hermouet
Adrien Bosseboeuf, Delphine Feron, Anne Tallet, Cédric Rossi, Cathy Charlier, Laurent Garderet, Denis Caillot, Philippe Moreau, Marina Cardó-Vila, Renata Pasqualini, Wadih Arap, Alfreda Destea Nelson, Bridget S. Wilson, Hélène Perreault, Eric Piver, Pierre Weigel, François Girodon, Jean Harb, Edith Bigot-Corbel, Sylvie Hermouet
View: Text | PDF
Research Article Immunology

Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens

  • Text
  • PDF
Abstract

Subsets of mature B cell neoplasms are linked to infection with intracellular pathogens such as Epstein-Barr virus (EBV), hepatitis C virus (HCV), or Helicobacter pylori. However, the association between infection and the immunoglobulin-secreting (Ig-secreting) B proliferative disorders remains largely unresolved. We investigated whether the monoclonal IgG (mc IgG) produced by patients diagnosed with monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM) targets infectious pathogens. Antigen specificity of purified mc IgG from a large patient cohort (n = 244) was determined using a multiplex infectious-antigen array (MIAA), which screens for reactivity to purified antigens or lysates from 9 pathogens. Purified mc IgG from 23.4% of patients (57 of 244) specifically recognized 1 pathogen in the MIAA. EBV was the most frequent target (15.6%), with 36 of 38 mc IgGs recognizing EBV nuclear antigen-1 (EBNA-1). MM patients with EBNA-1–specific mc IgG (14.0%) showed substantially greater bone marrow plasma cell infiltration and higher β2-microglobulin and inflammation/infection–linked cytokine levels compared with other smoldering myeloma/MM patients. Five other pathogens were the targets of mc IgG: herpes virus simplex-1 (2.9%), varicella zoster virus (1.6%), cytomegalovirus (0.8%), hepatitis C virus (1.2%), and H. pylori (1.2%). We conclude that a dysregulated immune response to infection may underlie disease onset and/or progression of MGUS and MM for subsets of patients.

Authors

Adrien Bosseboeuf, Delphine Feron, Anne Tallet, Cédric Rossi, Cathy Charlier, Laurent Garderet, Denis Caillot, Philippe Moreau, Marina Cardó-Vila, Renata Pasqualini, Wadih Arap, Alfreda Destea Nelson, Bridget S. Wilson, Hélène Perreault, Eric Piver, Pierre Weigel, François Girodon, Jean Harb, Edith Bigot-Corbel, Sylvie Hermouet

×

Figure 12

Cytokine levels in serum of MGUS and SM/MM patients with infectious pathogen–specific or EBNA-1–specific mc IgG.

Options: View larger image (or click on image) Download as PowerPoint
Cytokine levels in serum of MGUS and SM/MM patients with infectious path...
Six cytokines were quantified in serum using Luminex technology (Bio-Plex 200) with Bio-Plex Pro Human Cytokine Panel kits (Bio-Rad) in 3 different groups: healthy donors (HD, n = 9), monoclonal gammopathy of undetermined significance (MGUS) patients (n = 34), and a group of 4 smoldering myeloma (SM) patients and 26 multiple myeloma (MM) patients (designated as MM; n = 30). The MGUS and SM/MM groups were subdivided according to the pathogen specificity of monoclonal (mc) IgG: patients with mc IgG specific for one of the infectious pathogens from the multiplex infectious-antigen array (MIAA) assay are designated as MIAA+ patients; all others are designated as MIAA– patients. Patients with EBV nuclear antigen-1–specific (EBNA-1–specific) mc IgG are designated as EBNA-1+ patients; all others are designated as EBNA-1–. The cytokines measured were (A) HGF, (B) IL-6, (C) IL-10, (D) IL-22, (E) IL-26, and (F) IL-33. Cytokine levels were measured in serum from MIAA+/– and EBNA1+/– MM patients. (G) Serum IL-33 levels of MIAA+/– and EBNA1+/– MGUS patients. Note that the scales for IL-33 concentrations are different in F and G. For a given patient, results are means of technical duplicate measurements, expressed in pg/ml. Median values of groups of patients are shown as bars; means are indicated with the + symbol. Normal cytokine values in blood of healthy donors are as follows: HGF, 63–1,283 pg/ml; IL-6, < 9 pg/ml (in our group of HD, one individual had 165.5 pg/ml IL-6); IL-10, < 2 pg/ml; IL-22, 0 pg/ml; IL-26 and IL-33, normal values are not defined. *P < 0.05, **P < 0.01, and ***P < 0.001 by ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts